Skip to Main Content

Paper Details

Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC.
J Immunother Cancer
24
2021
-catenin, CCL28, CD4, CD8, MDA5, PD-L1, RCC, RIG-I, T-cell, T-cell receptor, TCR, Wnt, ccRCC, clear cell renal cell carcinoma, genomic, hypoxia-regulated genes, metastatic ccRCC, nivolumab, patient, patients, programmed death ligand-1, programmed death-1 receptor, sunitinib, tumor types, tumors
Author NameAffiliation
Alice M Walsh
Toni K ChoueiriThe Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, and Harvard Medical School
  • 1 - 2

Datasets

Release 1.2